|CrossRef Text and Data Mining|
|Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.|
|Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?|
|Tae Wan Kim, Hong Joo Kim, Chang Uk Chon, Hyun Sun Won, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim|
|Clin Mol Hepatol. 2012;18(2):203-212. Published online 2012 June 26 DOI: https://doi.org/10.3350/cmh.2012.18.2.203|
Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?
CON (“The window is closed”): In patients with cirrhosis with ascites, the clinical risks of nonselective beta-blocker outweigh the benefits and should NOT be prescribed
Low-dose captopril for patients with liver cirrhosis: What is low?
Continuation of nonselective beta-blockers for patients with liver cirrhosis and hemodynamic nonresponse?
Does the dose and type of nonselective beta-blocker really matter?
PRO (“The Window Is Open”): In patients with cirrhosis with prior variceal hemorrhage and ascites, the clinical benefits of nonselective beta-blockers outweigh the risks and should be prescribed
Carvedilol, a new nonselective beta-blocker with intrinsic anti-alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis
Effects of the beta-blocker, nadolol, on liver hemodynamics and function in patients with liver cirrhosis
LIVER CIRRHOSIS CAN CHANGE HISTAMINE H2-BLOCKER KINETICS
Stage of cirrhosis predicts the risk of liver-related death in patients with low model for End-Stage liver disease scores and cirrhosis awaiting liver transplantation
|This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.|